US Patent Issued to Janssen Biotech on Oct. 20 for "Anti-BCMA antibodies and uses thereof" (Pennsylvania Inventors)

ALEXANDRIA, Va., Oct. 21 -- United States Patent no. RE51,085, issued on Oct. 20, was assigned to Janssen Biotech Inc. (Horsham, Pa.).

"Anti-BCMA antibodies and uses thereof" was invented by Kodandaram Pillarisetti (Spring House, Pa.), Eric Thomas Baldwin (Spring House, Pa.), Gordon D. Powers (Spring House, Pa.), Rosa Maria Fernandes Cardosa (Spring House, Pa.), Ricardo Attar (Spring House, Pa.) and Francois Gaudet (Spring House, Pa.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are antibodies that immunospecifically bind to BCMA. Also described are related polynucleotides capable of encoding the provided BCMA-specific antibodies or antigen-binding fragments, cells expressing the provided an...